- All sections
- G - Physics
- G01N - Investigating or analysing materials by determining their chemical or physical properties
- G01N 33/557 - Immunoassay; Biospecific binding assay; Materials therefor using kinetic measurement, i.e. time rate of progress of an antigen-antibody interaction
Patent holdings for IPC class G01N 33/557
Total number of patents in this class: 242
10-year publication summary
9
|
13
|
17
|
30
|
18
|
16
|
16
|
17
|
33
|
8
|
2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Hoffmann-La Roche Inc. | 3060 |
11 |
Howard Hughes Medical Institute | 202 |
8 |
Cytiva Sweden AB | 741 |
8 |
Hound Labs, Inc. | 61 |
7 |
GE Healthcare Bio-Sciences AB | 570 |
6 |
F. Hoffmann-La Roche AG | 7958 |
5 |
Genentech, Inc. | 3742 |
4 |
Access Medical Systems, Ltd. | 62 |
4 |
Arizona Board of Regents on behalf of Arizona State University | 2226 |
4 |
The Brigham & Women's Hospital, Inc. | 50 |
4 |
Inanovate, Inc. | 15 |
4 |
Juno Therapeutics GmbH | 41 |
4 |
The Regents of the University of Michigan | 4409 |
3 |
Creoptix AG | 19 |
3 |
Ortho-Clinical Diagnostics, Inc. | 191 |
3 |
Siemens Healthcare Diagnostics Inc. | 1946 |
3 |
Technische Universiteit Eindhoven | 316 |
3 |
Roche Diagnostics Operations, Inc. | 1375 |
2 |
The Regents of the University of California | 18943 |
2 |
Church & Dwight Co., Inc. | 1845 |
2 |
Other owners | 152 |